Key facts
- This page summarizes Nancy E. Katz's Form 4 filing for NeuroMetrix, Inc. (NURO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 May 2024, 16:00.
Nancy E. Katz - 30 Apr 2024 Form 4 Insider Report for NeuroMetrix, Inc. (NURO)
- Reporting relationship
- Director
- Issuer ticker
- NURO
- Reported as of
- 30 Apr 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 May 2024, 16:00:42 UTC
- Prior SEC filing
- 04 Aug 2023
- Next SEC filing
- 24 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas T. Higgins, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nancy E. Katz filed Form 4 for NeuroMetrix, Inc. (NURO) on 02 May 2024.
Change
- Previous filing in this sequence was filed on 04 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NURO
transaction
Common Stock
Options Exercise
- Transaction value
- $23,581
- Shares
- +5,396
- Change %
- +245%
- Price
- $4.37
- Shares after
- 7,602
- Date
- 30 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NURO
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $23,581
- Shares
- -5,396
- Change %
- -100%
- Price
- $4.37
- Shares after
- 0
- Date
- 30 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,396
- Exercise price
- $4.37
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares earned upon the vesting of restricted stock units referred to in footnote 2.
Footnote F2
On August 4, 2023, the reporting person was granted 43,165 restricted stock units prior to the reverse stock split of the Issuer's common stock at a ratio 1-for-8, effective as of November 21, 2023, which vested 100% on April 30, 2024.